O
ISSUER//CIK 0001619551
Origo Acquisition Corp
Exchange
—
Entity type
operating
Fiscal year end
Nov 30
Headquarters
Cayman Islands
Recent Filings
- SC 13G/A135.8 KBOrigo Acquisition CorpFeb 13, 6:11 PM ET·0001461790-19-000013
- SC 13G/A34.4 KBOrigo Acquisition CorpSep 10, 3:17 PM ET·0001062993-18-003680
- 8-K20.7 KBOrigo Acquisition CorpAug 10, 5:26 PM ET·0001615774-18-007859
- 8-K32.0 KBOrigo Acquisition CorpJun 13, 4:05 PM ET·0001615774-18-005220
- 8-K46.7 KBOrigo Acquisition CorpMay 23, 5:30 PM ET·0001615774-18-004301
- 10-Q2.2 MBOrigo Acquisition CorpApr 13, 5:29 PM ET·0001615774-18-002638
- 8-K20.2 KBOrigo Acquisition CorpApr 12, 10:15 AM ET·0001615774-18-002562
- 8-K20.7 KBOrigo Acquisition CorpApr 5, 5:19 PM ET·0001144204-18-019428
- SC 13G/A77.1 KBOrigo Acquisition CorpMar 20, 11:15 AM ET·0000930413-18-001002
- SC 13G135.5 KBOrigo Acquisition CorpMar 19, 3:05 PM ET·0001461790-18-000017
Insiders
10- Avgerinos GeorgeCOO and Secretary
- Chill Adam J.Director
- Fortress Biotech, Inc.10% Owner
- FRED EDWARD JDirector, CEO and President, 10% Owner
- Herskowitz NeilDirector
- KORNBLUTH ARTHUR ASHERDirector
- Polar Asset Management Partners Inc.10% Owner
- Pudles StephenDirector
- ROSENWALD LINDSAY A MDDirector, Co-Chairman and CEO, 10% Owner
- WEISS MICHAEL SDirector, Co-Chairman of the Board
Tickers
No tickers on record
Addresses
business
24 NEW ENGLAND EXECUTIVE PARK SUITE 105
BURLINGTON, MA, 01803
mailing
24 NEW ENGLAND EXECUTIVE PARK SUITE 105
BURLINGTON, MA, 01803
Former Names
- CB Pharma Acquisition Corp.2016-06-10